Andra AP-fonden’s Idexx Laboratories IDXX Stock Holding History

Andra AP-fonden’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.6M	Sell	29,531 -8,789	-23%	-$5.64M	0.2%	119
2025 Q4	$25.9M	Buy	38,320 +8,420	+28%	+$5.73M	0.32%	88
2025 Q3	$19.1M	Buy	29,900 +25,177	+533%	+$15.3M	0.24%	141
2025 Q2	$2.53M	Sell	4,723 -13,077	-73%	-$6.25M	0.04%	328
2025 Q1	$7.48M	Sell	17,800 -15,900	-47%	-$6.9M	0.12%	246
2024 Q4	$13.9M	Buy	33,700 +5,000	+17%	+$2.19M	0.22%	177
2024 Q3	$14.5M	Sell	28,700 -1,800	-6%	-$874K	0.21%	167
2024 Q2	$14.9M	Buy	30,500 +9,000	+42%	+$4.52M	0.25%	131
2024 Q1	$11.6M	Buy	21,500 +12,500	+139%	+$6.83M	0.21%	157
2023 Q4	$5M	Sell	9,000 -3,400	-27%	-$1.6M	0.26%	171
2023 Q3	$5.42M	Sell	12,400 -400	-3%	-$199K	0.32%	156
2023 Q2	$6.43M	Sell	12,800 -9,200	-42%	-$4.41M	0.16%	292
2023 Q1	$11M	Buy	22,000 +6,500	+42%	+$3.11M	0.29%	77
2022 Q4	$6.32M	Sell	15,500 -8,400	-35%	-$3.26M	0.19%	229
2022 Q3	$7.79M	Buy	23,900 +1,800	+8%	+$661K	0.26%	125
2022 Q2	$7.75M	Buy	+22,100	New	+$9.01M	0.22%	171
2021 Q4	$19.4M	Buy	29,400 +100	+0.3%	+$62.8K	0.39%	18
2021 Q3	$18.2M	Buy	29,300 +1,200	+4%	+$806K	0.38%	16
2021 Q2	$17.7M	Buy	28,100 +2,200	+8%	+$1.21M	0.36%	12
2021 Q1	$12.7M	Buy	25,900 +3,100	+14%	+$1.55M	0.28%	60
2020 Q4	$11.4M	Sell	22,800 -1,600	-7%	-$716K	0.25%	92
2020 Q3	$9.59M	Buy	24,400 +6,600	+37%	+$2.44M	0.26%	77
2020 Q2	$5.88M	Buy	17,800 +700	+4%	+$203K	0.17%	249
2020 Q1	$4.14M	Sell	17,100 -2,800	-14%	-$731K	0.15%	319
2019 Q4	$5.2M	Buy	19,900 +900	+5%	+$237K	0.15%	355
2019 Q3	$5.17M	Buy	19,000 +1,900	+11%	+$529K	0.15%	332
2019 Q2	$4.71M	Sell	17,100 -10,800	-39%	-$2.66M	0.14%	396
2019 Q1	$6.24M	Buy	+27,900	New	+$5.76M	0.18%	221
2018 Q3	$9.96M	Sell	39,900 -600	-1%	-$146K	0.26%	58
2018 Q2	$8.83M	Buy	40,500 +1,700	+4%	+$350K	0.24%	82
2018 Q1	$7.43M	Buy	38,800 +26,700	+221%	+$4.93M	0.19%	178
2017 Q4	$1.89M	Sell	12,100 -5,900	-33%	-$929K	0.04%	580
2017 Q3	$2.8M	Sell	18,000 -6,000	-25%	-$949K	0.07%	461
2017 Q2	$3.87M	Sell	24,000 -4,100	-15%	-$666K	0.1%	332
2017 Q1	$4.34M	Buy	28,100 +900	+3%	+$124K	0.1%	293
2016 Q4	$3.19M	Buy	27,200 +12,000	+79%	+$1.37M	0.09%	373
2016 Q3	$1.71M	Sell	15,200 -3,700	-20%	-$390K	0.05%	505
2016 Q2	$1.75M	Buy	+18,900	New	+$1.62M	0.04%	555

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Andra AP-fonden's IDXX Position: Q1 2026 in Review

Andra AP-fonden reduced its Idexx Laboratories (IDXX) stake by 23% in Q1 2026, selling an estimated $5.64M and leaving 29,531 shares worth $16.6M. The position accounts for 0.2% of the portfolio, ranked #119.

Andra AP-fonden first reported a position in IDXX in Q2 2016 and has held it in 38 quarters since. The position peaked at $25.9M in Q4 2025. 1,318 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Andra AP-fonden held 29,531 shares of Idexx Laboratories worth $16.6M as of Q1 2026.
Andra AP-fonden sold 8,789 Idexx Laboratories shares in Q1 2026, an estimated $5.64M.
Idexx Laboratories made up 0.2% of Andra AP-fonden's portfolio in Q1 2026, its #119 holding.
Andra AP-fonden first reported a position in Idexx Laboratories in Q2 2016 and has held it in 38 quarters since.
Andra AP-fonden's Idexx Laboratories position peaked at $25.9M in Q4 2025.
1,318 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Andra AP-fonden's 13F filing for Q1 2026, filed 8 May 2026.